Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Diabetes Mellitus: Introduction01:26

Diabetes Mellitus: Introduction

Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Loneliness and Associated Factors Among Senior Physicians in the U.S.

American journal of lifestyle medicine·2025
Same author

Quality Improvement Summit 2016: Shared Decision Making and Prostate Cancer Screening.

Urology practice·2023
Same author

Type 2 diabetes patient activation and mHealth interventions decreased cardiovascular disease risk.

The American journal of managed care·2022
Same author

Mask-related skin changes among healthcare workers in a community-based hospital.

Journal of osteopathic medicine·2022
Same author

Improving diabetic patients' adherence to treatment and prevention of cardiovascular disease (Office Guidelines Applied to Practice-IMPACT Study)-a cluster randomized controlled effectiveness trial.

Trials·2022
Same author

Head to head randomized trial of two decision aids for prostate cancer.

BMC medical informatics and decision making·2021

Related Experiment Videos

A shared decision-making primary care intervention for type 2 diabetes.

William Corser1, Margaret Holmes-Rovner1, Catherine Lein1

  • 1The College of Nursing, Michigan State University, East Lansing (Dr Corser, Dr Holmes-Rovner, Ms Lein)

The Diabetes Educator
|August 9, 2007
PubMed
Summary

A brief shared decision-making (SDM) intervention is feasible for type 2 diabetes patients. This approach encourages documented diabetes management goals and shows potential for improving key health outcomes in primary care settings.

Related Experiment Videos

Area of Science:

  • Endocrinology
  • Primary Care Medicine
  • Health Psychology

Background:

  • Type 2 diabetes requires ongoing patient self-management.
  • Effective patient-provider communication is crucial for diabetes care.
  • Shared decision-making (SDM) models can enhance patient engagement.

Purpose of the Study:

  • To assess the feasibility of a brief SDM goal-setting intervention for type 2 diabetes patients.
  • To evaluate the impact of SDM on diabetes management goal documentation.
  • To explore potential improvements in clinical and patient-reported outcomes.

Main Methods:

  • Pilot study involving 58 patients with type 2 diabetes.
  • Intervention focused on brief shared decision-making for goal setting.
  • Outcomes measured included HbA1c, weight, blood pressure, patient surveys, and documented goals.

Main Results:

  • The SDM intervention was feasible and well-received by providers.
  • 75.9% of patients had at least one documented diabetes management goal post-intervention.
  • Significant increases in perceived knowledge and documented goals were observed; trends toward improvement in HbA1c, weight, and empowerment.

Conclusions:

  • A brief SDM intervention is feasible for type 2 diabetes management in primary care.
  • SDM can facilitate the documentation of realistic patient-provider diabetes goals.
  • Further research with larger randomized trials is recommended to confirm efficacy.